| 5 May 2012 |
| 08:00 17:00 | | Pre-Congress Course: Proper Medical Writing
For the full programme and to register for your place on this course, please visit the Medical Writing Course section on this website by clicking on the session title above.
Location: Magnolia
|
| 09:00 17:00 | | Insights Into Italian Endocrinology and Metabloism
For further information see http://web.aimgroupinternational.com/2012/sie/
LOC Satellite |
| 09:00 17:00 | | Pre-Congress Course: Thyroid Ultrasound
For the full programme, please visit the Thyroid Ultrasound Course section on this website by clicking on the session title above.
Location: Sherma
|
| 12:00 20:00 | | Registration
Location: Padiglione Centrale
Registration |
| 15:00 17:00 | | SANDOZ Satellite Symposia - Maturing metabolism: A neurondocrine affair
Chair(s): G. Stalla (Germany ) & T. Brue (France)
Location: Basilica
|
| 15:00 | | Chairman's Welcome
G. Stalla & T. Brue (Germany & France) |
| | | |
| 15:10 | | Searching in the wrong place: The endocannabinoid system revisited
U. Pagotto (Italy) |
| | | |
| 15:35 | | Metabolic control: It's a gut feeling
P.T. Pfluger (Germany) |
| | | |
| 16:00 | | Endocrine regulation of lifespan: Lessons from the animal models
J. Kopchick (USA) |
| | | |
| 16:25 | | Looking for longevity: Look in your genes
S. Lamberts (The Netherlands) |
| | | |
| 16:50 | | Closing remarks
G. Stalla (Germany) & T. Brue (France) |
| | | |
| 15:30 17:30 | | Emerging issues in Scientific Publishing: A Round Table Event
Teatrino
|
| | 1. Search for reviewers - a difficult task for editors
|
| | | |
| | 2. Rebuttal of negative editor's decision by authors and the immediate rejection of a paper: how to minimise the risk
|
| | | |
| | 3. Conflict of interest: what really needs to be declared
|
| | | |
| | 4. The H - index: why so mancy variables and how to discern
|
| | | |
| | 5. Ethical issues (duplication, plagiarism, conflict of interest)
|
| | | |
| | 6. Perspective for Journals in the Endocrine and Metabolic field
|
| | | |
| 17:30 19:30 | | ICE/ECE 2012 Opening Ceremony: Welcome & introduction
Main Lecture Hall
Chairs: Chair(s): F. Casanueva, ISE President (Spain) & P. Bouchard, ESE President (France)
|
| 17:30 | | Welcome to Florence & ICE/ECE 2012
M. Reincke & G. Forti (Germany & Italy) |
| | | |
| 17:45 | | Welcoming addresses
Invited guests
|
| | | |
| 17:55 18:40 | | Geoffrey Harris Prize Lecture
Main Lecture Hall
Chairs: Chair(s): P. Bouchard (France) & J. Castano (Spain)
|
| 17:55 | GH1 GH1 | Glucocorticoid metabolism and the brain, from fetal programming to senescence
J. Seckl (UK) |
| | | |
| 18:45 19:30 | | European Journal of Endocrinology Prize Lecture
Main Hall
Chair: Chair(s): J. Romijn - Editor-in-Chief of EJE (The Netherlands)
|
| 18:45 | EJE1 EJE1 | Tacklling obesity: lessons from genetics
S. Farooqi (UK) |
| | | |
| 19:30 21:00 | | ICE/ECE 2012 Welcome Reception
Generously Supported by Florence Convention Bureau
Sponsored by Endocrine Connections
Exhibition Hall
|
| 6 May 2012 |
| 07:00 20:00 | | Registration
|
| 08:30 09:15 | | Plenary Lecture 1
Location: Main Hall
Chair: Chair(s): E. Nieschlag (Germany)
|
| 08:30 | PL1 PL1 | Red wine endocrinology
D. Sinclair (USA) |
| | | |
| 09:15 09:25 | | Presidents' Address
P. Bouchard (France) & F Casanueva (Spain)
|
| 09:30 11:00 | | Symposium 1: Molecular mechanisms of differentiated thyroid cancer
Location: Main Hall
Chairs: Chair(s): R. Elisei (Italy) & B. Jarzab (Poland)
|
| 09:30 | S1.1 S1.1 | Molecular consequences of deregulated microRNAs in papilliary thyroid carcinoma
A. de la Chapelle (USA) |
| | | |
| 10:00 | S1.2 S1.2 | Correlation between the BRAF V600E mutation; TGF beta pathway and tumour invasiveness in papillary thyroid carcinoma
P. Santistebar (Spain) |
| | | |
| 10:30 | S1.3 S1.3 | Molecular genotyping of papillary thyroid carcinoma
M. Sobhrino-Simoes (Portugal) |
| | | |
| 09:30 11:00 | | Symposium 2: 40 years of male hormonal contraception research and no product
Location: Hall A
Chairs: Chair(s): E. Nieschlag (Germany) & F. Wu (UK)
|
| 09:30 | S2.1 S2.1 | Do we know enough about regulation of testicular function?
R. McLachlan (Australia) |
| | | |
| 10:00 | S2.2 S2.2 | Clinical trials in male hormonal contraception to date
C. Meriggiola (Italy) |
| | | |
| 10:30 | S2.3 S2.3 | Acceptability of male hormonal contraception by the pharmaceutical industry and by the consumer
F. Saad (Germany) |
| | | |
| 09:30 11:00 | | Symposium 3: Absolute fracture risk assessment with FRAX
Location: Hall B
Chairs: Chair(s): F. Cetani (Italy) & R. Rizzoli (Switzerland)
|
| 09:30 | S3.1 S3.1 | Overview of FRAX
J. Kanis (UK) |
| | | |
| 10:00 | S3.2 S3.2 | Use of FRAX in Asian populations
L. Koh (Singapore) |
| | | |
| 10:30 | S3.3 S3.3 | Beyond FRAX
J. Eisman (Australia) |
| | | |
| 09:30 11:00 | | Symposium 4: The gut nutrient sensing in energy metabolism
Location: Hall C
Chairs: Chair(s): H. Itoh (Japan) & C. Rotella (Italy)
|
| 09:30 | S4.1 S4.1 | Bile acid metabolism for the control of metabolic disease
M. Watanbe (Japan) |
| | | |
| 10:00 | S4.2 S4.2 | Taste receptors in gut regulate endocrine function
R. Margolskee (USA) |
| | | |
| 10:30 | S4.3 S4.3 | Gut microbiome and energy metabolism: The concept of micro-obesity
P. Cani (Belgium) |
| | | |
| 09:30 11:00 | | Symposium 5: Transition from paediatric to adult care - do we have progress?
Location: Hall D
Chairs: Chair(s): C. Hoybye (Sweden) & P. Garofalo (Italy)
|
| 09:30 | S5.1 S5.1 | Prader-Willi syndrome childhood and adult life: Outcome report from a consensus workshop
C. Deal (Canada) |
| | | |
| 10:00 | S5.2 S5.2 | Fertility options for young adults with panhypopituitarism
M. Wierman (USA) |
| | | |
| 10:30 | S5.3 S5.3 | Sex steroid replacement in young males and females
G. Conway (UK) |
| | | |
| 09:30 11:00 | | Symposium 6: Subclinical adrenal diseases
Location: Hall E
Chairs: Chair(s): A. Lacroix (Canada) & E. Husebye (Norway)
|
| 09:30 | S6.1 S6.1 | Diagnosis and treatment of subclinical Cushing's syndrome (SCS)
T. Yanase (Japan) |
| | | |
| 10:00 | S6.2 S6.2 | Silent phaeochromocytoma
R. Clifton-Bligh (Australia) |
| | | |
| 10:30 | S6.3 S6.3 | Subclinical Addison's disease
A. Falorni (Italy) |
| | | |
| 09:30 11:00 | | Symposium 7: Hormones, metabolism and cancer: more than coincidences?
Location: Hall F
Chairs: Chair(s): C. Strasberger (Germany) & A. Dunaif (USA)
|
| 09:30 | S7.1 S7.1 | An epigenetic switch linking inflammation to cancer and the use of metaformin as an anti-cancer drug
K. Struhl (USA) |
| | | |
| 10:00 | S7.2 S7.2 | The insulin-like growth factor system and cancer: What are the implications?
D. Le Roith (USA) |
| | | |
| 10:30 | S7.3 S7.3 | Obesity and cancer
A. Renehan (UK) |
| | | |
| 09:30 11:00 | | Symposium 8: Global phenotypes of endocrine disease
Location: Hall G
Chairs: Chair(s): P. Bouchard (France) & B. Allolio (Germany)
|
| 09:30 | S8.1 S8.1 | Vitamin D deficiency in Asia
G. El-hajj Fuleihan (Lebanon) |
| | | |
| 10:00 | S8.2 S8.2 | Ethnic specific PCOS
C. Wijeyaratne (Sri Lanka) |
| | | |
| 10:30 | S8.3 S8.3 | TBC
TBC |
| | | |
| 09:30 11:00 | | Symposium 9: The risk and benefits of tight glycaemic control
Location: Hall H
Chairs: Chair(s): S. del Prato (Italy) & W. Sheu (Taiwan)
|
| 09:30 | S9.1 S9.1 | What do type 2 diabetes outcome trials tell us about the cardiovascular risks and benefits of intensive glycaemic control?
H. Gerstein (Canada) |
| | | |
| 10:00 | S9.2 S9.2 | Tight control of blood glucose levels in the hospitalised patient
M. Korytkowski (USA) |
| | | |
| 10:30 | S9.3 S9.3 | Time course of the glucose legacy effect
R. Holman (UK) |
| | | |
| 11:00 11:30 | | Coffee, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 11:30 12:30 | | Debate 1: This house believes that metabolic (bariatric) surgery should be offered to every diabetic with a BMI over 30
For: G. Mingrone (Italy); Against: E. Mannucci (Italy)
Location: Main Hall
Chair: Chair(s): V. Pirags (Latvia)
|
| 11:30 12:15 | | Meet the Expert 1
Location: Hall A
|
| 11:30 | MTE1 MTE1 | Adrenal incidentaloma and subclinical Cushing's syndrome
P. Stewart (UK) |
| | | |
| 11:30 12:15 | | Meet the Expert 2
Location: Hall B
|
| 11:30 | MTE2 MTE2 | Approach to the patient with Cushing's disease after pituitary surgery failure
M. Toth (Hungary) |
| | | |
| 11:30 12:15 | | Meet the Expert 3
Location: Hall C
|
| 11:30 | MTE3 MTE3 | Osteoporosis in men
U. Gruntmanis (USA) |
| | | |
| 11:30 12:15 | | Meet the Expert 4
Location: Hall D
|
| 11:30 | MTE4 MTE4 | Challenges of transsphenoidal pituitary surgery
P. Cappabianca (Italy) |
| | | |
| 11:30 12:15 | | Meet the Expert 5
Location: Hall E
|
| 11:30 | MTE5 MTE5 | Discussion of common but difficult thyroid cancer cases
L. Wartofsky (USA) |
| | | |
| 11:30 12:15 | | Meet the Expert 6
Location: Hall F
|
| 11:30 | MTE6 MTE6 | Clinical management of adrenocortical carcinoma
M. Terzolo (Italy) |
| | | |
| 11:30 12:15 | | Meet the Expert 7
Location: Hall G
|
| 11:30 | MTE7 MTE7 | Pregnancy and pituitary disorders
Z. Karaca (Turkey) |
| | | |
| 11:30 12:15 | | Meet the Expert 8
Location: Hall H
|
| 11:30 | MTE8 MTE8 | Diagnosis and treatment of precocious puberty
L. Ghizzoni (Italy) |
| | | |
| 12:25 13:10 | | Meet the Expert 9
Location: Hall A
|
| 12:25 | MTE9 MTE9 | Diagnosis and treatment of SIADH
C. Thompson (Ireland) |
| | | |
| 12:25 13:10 | | Meet the Expert 10
Location: Hall B
|
| 12:25 | MTE10 MTE10 | Elastosonography in the evaluation of thyroid and parathyroid lesions
M. Erdogan (Turkey) |
| | | |
| 12:25 13:10 | | Meet the Expert 11
Location: Hall C
|
| 12:25 | MTE11 MTE11 | Diagnosis and treatment considerations in autoimmune polyendocrine syndrome
O. Kampe (Sweden) |
| | | |
| 12:25 13:10 | | Meet the Expert 12
Location: Hall D
|
| 12:25 | MTE12 MTE12 | Goitre throughout the paediatric ages
M. Polak (France) |
| | | |
| 12:25 13:10 | | Meet the Expert 13
Location: Hall E
|
| 12:25 | MTE13 MTE13 | Graves' ophthalmopathy
W. Wiersinga (The Netherlands) |
| | | |
| 12:25 13:10 | | Meet the Expert 14
Location: Hall F
|
| 12:25 | MTE14 MTE14 | Hirsutism
K. Unluhizarci (Turkey) |
| | | |
| 12:25 13:10 | | Meet the Expert 15
Location: Hall G
|
| 12:25 | MTE15 MTE15 | Pituitary tumours in adolescents and adults
M. Andersen (Denmark) |
| | | |
| 12:25 13:10 | | Meet the Expert 16
Location: Hall H
|
| 12:25 | MTE16 MTE16 | Management of non-functioning pituitary adenomas
N. Karavitaki (UK) |
| | | |
| 12:30 13:15 | | Lunch, Posters & Exhibition
ESE President meets ESE Affiliated Society Presidents (invitation only)
Exhibition Hall & Poster Hall
|
| 13:15 14:45 | | Symposium 10: Thyroid: From fetal life to adulthood
Location: Hall A
Chairs: Chair(s): K. Brix (Germany) & S. Gullu (Turkey)
|
| 13:15 | S10.1 S10.1 | Placental transport of thyroid hormone
S. Chan (UK) |
| | | |
| 13:45 | S10.2 S10.2 | Importance of fetal life for adult thyroid disease
R. Gartner (Germany) |
| | | |
| 14:15 | S10.3 S10.3 | Thyroid hormones and fetal neurological development
M. Li (Australia) |
| | | |
| 13:15 14:45 | | Symposium 11: Novel genetic and endocrine insights in the Klinefelter's syndrome
Location: Hall B
Chairs: Chair(s): K. Kula (Poland) & R. Swerdloff (USA)
|
| 13:15 | S11.1 S11.1 | Klinefelter mouse (47XXY): Model for human klinefelter syndrome
R. Swerdloff (USA) |
| | | |
| 13:45 | S11.2 S11.2 | Endocrine changes in klinefelter's syndrome and the effects on growth, bone and body composition
L. Aksglaede (Denmark) |
| | | |
| 14:15 | S11.3 S11.3 | The Muenster EXAKT project: Epigenetic regulation of the supernumerary X chromosome and its escape genes
J. Gromoll (Germany) |
| | | |
| 13:15 14:45 | | Symposium 12: Determinants of peak bone mass
Location: Hall C
Chairs: Chair(s): R. Prince (Australia) & K. Brixen (Denmark)
|
| 13:15 | S12.1 S12.1 | Epidemiology of peak bone mass, structure and strength in males as assessed by high resolution peripheral quantitative CT (HR-pQCT). A cross-sectional study.
K. Brixen (Denmark) |
| | | |
| 13:45 | S12.2 S12.2 | The contribution of genetic factors to bone mass
W. van Hul (Belgium) |
| | | |
| 14:15 | S12.3 S12.3 | Estrogens as regulators of bone growth and bone mass
C. Ohlsson (Sweden) |
| | | |
| 13:15 14:45 | | Symposium 13: Novel therapies for protecting beta cell function at diagnosis of type 1 diabetes
Location: Hall D
Chairs: Chair(s): I. Satman (Turkey) & R. Buzzetti (Italy)
|
| 13:15 | S13.1 S13.1 | Therapy with anti-CD3 monoclonal antibody
R. Buzzetti (Italy) |
| | | |
| 13:45 | S13.2 S13.2 | Peptide therapy (Diapepe277)
R. Itamar (Israel) |
| | | |
| 14:15 | S13.3 S13.3 | Therapy with glutamic acid decarboxylase (GAD)
J. Ludvigsson (Sweden) |
| | | |
| 13:15 14:45 | | Symposium 14: Wnt/Beta-catenin in pituitary development and disease
Location: Hall E
Chairs: Chair(s): A. Spada (Italy) & G. Stalla (Germany)
|
| 13:15 | S14.1 S14.1 | Wnt/Beta-catenin in pituitary development
S. Camper (USA) |
| | | |
| 13:45 | S14.2 S14.2 | Wnt/Beta-catenin signalling in craniopharyngioma
J.P. Martinez-Barbera (UK) |
| | | |
| 14:15 | S14.3 S14.3 | Wnt signalling in oestrogen induced lactotroph proliferation
J. Davis (UK) |
| | | |
| 13:15 14:45 | | Symposium 15: Adrenal cancer
Location: Hall F
Chairs: Chair(s): B. Skogseid (Sweden) & V. Toscano (Italy)
|
| 13:15 | S15.1 S15.1 | Molecular pathogenisis of adrenocortical cancer
E. Lalli (France) |
| | | |
| 13:45 | S15.2 S15.2 | Imaging of adrenocortical cancer
I. Ilias (Greece) |
| | | |
| 14:15 | S15.3 S15.3 | Genetics of micronodular hyperplasias (associated with Cushing syndrome)
C. Stratakis (USA) |
| | | |
| 13:15 14:45 | | Symposium 16: Understanding growth
Location: Hall G
Chairs: Chair(s): F. Minuto (Italy) & M. Andersen (Denmark)
|
| 13:15 | S16.1 S16.1 | From Galton to GWAS (and beyond): what we have learned about the genetics of human height?
P. Visscher (Australia) |
| | | |
| 13:45 | S16.2 S16.2 | Genes and the investigation of idiopathic short stature (ISS): are we ready for prime time?
J-M. Wit (The Netherlands) |
| | | |
| 14:15 | S16.3 S16.3 | What is the optimal growth of small gestational age (SGA) babies: lessons from WHO?
S. Chernausek (USA) |
| | | |
| 13:15 14:45 | | Symposium 17: Hormonal control of pregnancy
Location: Hall H
Chairs: Chair(s): G. Bartfai (Hungary) & Z. Karaca (Turkey)
|
| 13:15 | S17.1 S17.1 | Hormone signalling between mother and foetus
R. Reynolds (UK) |
| | | |
| 13:45 | S17.2 S17.2 | What controls labour in humans?
R. Smith (Australia) |
| | | |
| 14:15 | S17.3 S17.3 | Placental hormones as putative markers of gestational diseases
F. Petraglia (Italy) |
| | | |
| 14:45 15:15 | | Coffee, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 15:15 16:45 | | Symposium 18: Molecular mechanisms in autoimmune thyroid disease
Location: Hall A
Chairs: Chair(s): M. Tonacchera (Italy) & M. Marazuela (Spain)
|
| 15:15 | S18.1 S18.1 | Predictors of relapse of Graves' disease after antithyroid drug withdrawal
P-W. Wang (Taiwan) |
| | | |
| 15:45 | S18.2 S18.2 | Genotype-phenotype correlations in Grave's disease
T. Bednarczuk (Poland) |
| | | |
| 16:15 | S18.3 S18.3 | Regulatory cells, Th17 lymphocytes, and dendritic cells in autoimmune thyroid disease
M. Marazuela (Spain) |
| | | |
| 15:15 16:45 | | Symposium 19: Controversies in testosterone replacement
Location: Hall B
Chairs: Chair(s): J-M. Kaufman (Belgium) & R. Legro (Italy)
|
| 15:15 | S19.1 S19.1 | Can we really measure testosterone?
R. Legro (USA) |
| | | |
| 15:45 | S19.2 S19.2 | Late onset hypogonadism - who should receive testosterone?
J. Svartberg (Norway) |
| | | |
| 16:15 | S19.3 S19.3 | Testosterone for women: why, when and how?
S. Davis (Australia) |
| | | |
| 15:15 16:45 | | Symposium 20: Signalling to and from osteoclasts
Location: Hall C
Chairs: Chair(s): J. Bollerslev (Norway) & X. Cao ( USA)
|
| 15:15 | S20.1 S20.1 | Efferent signalling by osteoclasts
K. Matsuo (Japan) |
| | | |
| 15:45 | S20.2 S20.2 | Immune signalling in osteoclasts
H. Takayanagi (Japan) |
| | | |
| 16:15 | S20.3 S20.3 | TGF beta brings osteoclasts to sites of resorbtion
X. Cao (USA) |
| | | |
| 15:15 16:45 | | Symposium 21: Obesity and reproduction
Location: Hall D
Chairs: Chair(s): M. Tena-Sempere (Spain) & R. Pasquali (Italy)
|
| 15:15 | S21.1 S21.1 | Integrating hypothalamic regulation of energy homeostasis and reproduction
C. Elias (USA) |
| | | |
| 15:45 | S21.2 S21.2 | Impact of obesity on male reproduction
A.C. Martini (Argentina) |
| | | |
| 16:15 | S21.3 S21.3 | Lifestyle modification and fertility
R. Norman (Australia) |
| | | |
| 15:15 16:45 | | Symposium 22: Pituitary tumourigenesis
Location: Hall E
Chairs: Chairs: I. Huhtaniemi (UK) & L. Hofland (The Netherlands)
|
| 15:15 | S22.1 S22.1 | Molecular mechanisms: the genes involved in pituitary tumorigenesis
S. Melmed (USA) |
| | | |
| 15:45 | S22.2 S22.2 | Tracing back a gene's influence
M. Korbonits (UK) |
| | | |
| 16:15 | S22.3 S22.3 | Pituitary tumourigenesis
A. Daly (Belgium) |
| | | |
| 15:15 16:45 | | Symposium 23: Advances in regulation of aldosterone synthesis
Location: Hall F
Chairs: Chair(s): H. Shibata (Japan) & F. Beuschlein (Germany)
|
| 15:15 | S23.1 S23.1 | Regulation of aldosterone synthase expression in normal adrenal and primary aldosteronism
W. Rainey (USA) |
| | | |
| 15:45 | S23.2 S23.2 | Extra-adrenal aldosterone biosynthesis
C. Gomez-Sanchez (USA) |
| | | |
| 16:15 | S23.3 S23.3 | Role of N-type calcium channel blockers in aldosterone biosynthesis
M. Yoshimura (Japan) |
| | | |
| 15:15 16:45 | | Symposium 24: Diabetes in children
Location: Hall G
Chairs: Chair(s): M. Craig (USA) & F. Amara (Egypt)
|
| 15:15 | S24.1 S24.1 | Epidemiology of ketoacidosis: Can we influence the incidence
H. Bui (Canada) |
| | | |
| 15:45 | S24.2 S24.2 | Hypotheses explaining the increase in type 1 diabetes
M. Knip (Finland) |
| | | |
| 16:15 | S24.3 S24.3 | Type 2 diabetes in children
M. Craig (Australia) |
| | | |
| 15:15 16:45 | | Symposium 25: Reproductive hormone action
Location: Hall H
Chairs: Chair(s): TBC & J. Gromoll (Germany)
|
| 15:15 | S25.1 S25.1 | GnRH receptor signalling
U. Kaiser (USA) |
| | | |
| 15:45 | S25.2 S25.2 | Light on the structural communication in gonadotrophin hormone receptors: implications in genetic diseases
F. Fanelli (Italy) |
| | | |
| 16:15 | S25.3 S25.3 | Extragonadal follicle stimulating hormone action - facts and dreams
N. Ghinea (France) |
| | | |
| 17:00 17:45 | | Plenary Lecture 2
Location: Main Hall
Chair: Chair(s): G. Forti (Italy)
|
| 17:00 | PL2 PL2 | Testosterone - More than sex
M. Maggi (Italy) |
| | | |
| 17:45 18:00 | | In Memoriam
Location: Main Hall
Chairs: Chair(s): P. Bouchard (France) & F. Casaneuva (Spain)
|
| 18:00 19:30 | | Poster Reception
Attended poster session, refreshments available
Poster Hall
|
| 18:30 20:00 | | VIROPHARMA Satellite Symposia - Challenges of glucocorticoid replacement therapy in adrenal insufficiency
Location: Teatrino
Chair: B.M.K. Biller
|
| 18:30 | | Introduction
B.M.K. Biller |
| | | |
| 18:40 | | Management of Addison's disease, why are we failing our patients
P.M. Stewart |
| | | |
| 19:00 | | Stress response and prevention of adrenal crisis in chronic adrenal insufficiency
S.S. Hahner |
| | | |
| 19:20 | | Difficult cases such as pregnancy and concomittant type 1 diabetes mellitus
J.P. Monsson |
| | | |
| 19:40 | | The cortisol concentration time profile and metabolic outcome
G. Johannsson (Sweden) |
| | | |
| 19:55 | | Closing remarks
B.M.K. Biller |
| | | |
| 18:30 20:00 | | ALEXION PHARMACEUTICALS Satellite Symposia - Uncommon causes of fractures: Differential diagnosis and innovative treatment options
Location: Hall H
Chair: Chair(s): M.L. Brandi
|
| 18:30 | | Introduction & Welcome
M.L. Brandi |
| | | |
| 18:35 | | Review Skeletal Mineralization
M.L. Brandi |
| | | |
| 18:50 | | Paget's Disease
L. Gennari |
| | | |
| 19:10 | | Osteoporosis
R. Eastell |
| | | |
| 19:30 | | Hypophosphatasia
C. Kasperk |
| | | |
| 19:50 | | Q&A and Closing Remarks
M.L. Brandi |
| | | |
| 18:30 20:00 | | IBSA Satellite Symposia - Therapy of hypothyroidism: adult and child confronted. Experiences with levothyroxine in oral solution
Location: Hall F
Chairs: Chair(s): P. Vitti (Pisa, Italy) & M. Cappa (Rome, Italy)
|
| 18:15 | | Welcome and introduction
M. Cappa (Rome, Italy) |
| | | |
| 18:20 | | Pharmacokinetics of L-thyroxine in oral solution vs solid dosage forms
M.P. Ducharme (Canada) |
| | | |
| 18:35 | | L-thyroxine: more oral forms for a fine individual dose calibration
M. Centanni & S. Benvenge (Rome & Messina, Italy) |
| | | |
| 19:05 | | Therapy of congenital hypothyroidism: the experience of two Italian centres with liquid L-thyroxine
A. Cassio & G. Weber (Italy & Italy) |
| | | |
| 19:35 | | Discussion
P. Vitti (Pisa, Italy) |
| | | |
| 19:45 | | End of session
|
| | | |
| 18:30 20:00 | | OTSUKA Satellite Symposia - Head to head in hyponatraemia: Comparing clinical approaches
Location: Hall G
Chair: J. Verballs (USA)
|
| 18:30 | | Welcome: What is your hyponatraemia mind-set?
J. Verballs (USA) |
| | | |
| 18:35 | | Everyday issues in hyponatraemia: What would you do?
J. Verballs (USA) |
| | | |
| 18:55 | | Applying clinical data to real-life decisions on hyponatraemia management: Experience from the front line
Case 1 - Comprehensive diagnosis
A. Peri (Italy) |
| | | |
| 19:20 | | Applying clinical data to real-life decisions on hyponatraemia management: Experience from the front line
Case 2 - Optimising treatment
C. Thompson (Ireland) |
| | | |
| 19:45 | | Revisiting our hyponatraemia patients: has the mind-set changed?
J. Verballs (USA) |
| | | |
| 19:55 | | Questions & Answers
|
| | | |
| 18:30 20:00 | | PFIZER Satellite Symposia - Metabolic Consequences of Medical Treatment for Acromegaly
Location: Hall A
Chairs: Chair(s): Ezio Ghigo (Italy) & Christian Strasburger (Germany)
|
| 18:30 | | Clinical significance of metabolic perturbations in acromegaly
K. Ho (Australia) |
| | | |
| 18:50 | | Body composition and lipid changes during the treatment of acromegaly
P. Chanson (France) |
| | | |
| 19:10 | | Differential effects on glycaemia of SSAs (old & new) vs Pegvisomant
W. Drake (UK) |
| | | |
| 19:30 | | Ever heard of extra-hepatic acromegaly?
A.J. van der Lely (The Netherlands) |
| | | |
| 20:30 00:00 | | ICE/ECE 2012 Congress Dinner
Tickets should be purchased during registration
Palazzo Corsini
|
| 7 May 2012 |
| 07:00 20:00 | | Registration
|
| 08:30 09:15 | | Plenary Lecture 3
Location: Main Hall
Chair: Chair(s): M. Reincke (Germany)
|
| 08:30 | PL3 PL3 | Mating, sex and the immune system in humans and fish
M. Milinski (Germany) |
| | | |
| 09:30 11:00 | | Oral Communication Session 1 - Pituitary Clinical I
Location: Hall A
Chairs: Chair(s): M. Marazuela (Spain) & P. Burman (Sweden)
|
| 09:30 | OC1.1 OC1.1 | Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study
A-M. Colao (Italy) |
| | | |
| 09:45 | OC1.2 OC1.2 | Patients with Cushing’s disease achieve normal urinary cortisol with LCI699, a potent 11β-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study
X. Bertagna (France) |
| | | |
| 10:00 | OC1.3 OC1.3 | Efficacy and safety of long-term treatment with pegvisomant in acromegaly: Italian pegvisomant observational study (acrostudy)
A. Bianchi (Italy) |
| | | |
| 10:15 | OC1.4 OC1.4 | A multi-centre audit of the prevalence of cardiac valvulopathy in patients treated with dopamine agonists for hyperprolactinaemia
W. Drake (UK) |
| | | |
| 10:30 | OC1.5 OC1.5 | Initial hypothalamic involvement is the major risk factor for impaired prognosis and quality of life in childhood craniopharyngioma regardless of chosen treatment strategies – Results of KRANIOPHARYNGEOM 2000
H. Müller (Germany) |
| | | |
| 10:45 | OC1.6 OC1.6 | Normal weight adult patients with Prader-Willi syndrome are not protected from insulin resistance during treatment with growth hormone: Results from a 12 month prospective study
A. Jørgensen (Norway) |
| | | |
| 09:30 11:00 | | Oral Communication Session 2 - Thyroid Clinical I
Location: Hall B
Chairs: Chair(s): L. Bartalena (Italy) & I. Al-Ibrashy (Egypt)
|
| 09:30 | OC2.1 OC2.1 | Overt hyperthyroidism is associated with increased mortality. A nationwide register-based study of disease discordant Danish twins
F. Brandt (Denmark) |
| | | |
| 09:45 | OC2.2 OC2.2 | Identification and functional analysis of DUOX2 variants: Bialleclic mutations are associated with permanent congenital hypothyroidism
M. Muzza (Italy) |
| | | |
| 10:00 | OC2.3 OC2.3 | Thyroid hormone levels in euthyroid young men are associated with body composition and metabolic parameters
G. Roef (Belgium) |
| | | |
| 10:15 | OC2.4 OC2.4 | The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis
C. Moran (UK) |
| | | |
| 10:30 | OC2.5 OC2.5 | Thyroid spongiform nodules are the best candidates for percutaneous laser ablation. A 5 year follow-up study in 72 patients
G. S. Bortolani (Italy) |
| | | |
| 10:45 | OC2.6 OC2.6 | Concurrent presence of nonendocrine autoimmune diseases with Hashimoto's thyroiditis: A systematic assessment on more than 5000 consecutive patients
M. Cetanni (Italy) |
| | | |
| 09:30 11:00 | | Oral Communication Session 3 - Diabetes Clinical
Location: Hall C
Chairs: Chair(s): V. Pirags (Latvia) & K. Abdalla (Egypt)
|
| 09:30 | OC3.1 OC3.1 | Common variants of monogenic diabetes genes may affect beta cell functional mass in patients with newly diagnosed type 2 diabetes
S. Bonetti (Italy) |
| | | |
| 09:45 | OC3.2 OC3.2 | Weight-loss independent metabolic benefits of gastric bypass surgery? Experiences from the Swedish Obese Subjects (SOS) study
M. Peltonen (Finland) |
| | | |
| 10:00 | OC3.3 OC3.3 | Diabetic ketoacidosis at diagnosis influences complete remission after treatment of hematopoietic stem cell transplantation in adolescents with type 1 diabetes
W. Gu (China) |
| | | |
| 10:15 | OC3.4 OC3.4 | Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes
S. Loacara (Romania) |
| | | |
| 10:30 | OC3.5 OC3.5 | Study of toll like receptor 2 and 4 expression in monocytes in type 1 diabetes mellitus with and without micro-vascular complications
R. Abd El Baki (Egypt) |
| | | |
| 10:45 | OC3.6 OC3.6 | Glucose disorders exert a detrimental effect on total brain volume in the elderly: a 2-year prospective MRI study
K. Samaras (Australia) |
| | | |
| 09:30 11:00 | | Oral Communication Session 4 - Pituitary Basic
Location: Hall D
Chairs: Chair(s): L. Hofland (The Netherlands) & M. Theodoropoulou (Germany)
|
| | Blank Abstract
|
| | | |
| 09:30 | OC4.1 OC4.1 | Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in primates and mice
R. Luque (Spain) |
| | | |
| 09:45 | OC4.2 OC4.2 | Transcriptional regulation of prolactin by oestrogen in vivo.
A. Patist (UK) |
| | | |
| 10:00 | OC4.3 OC4.3 | miR-26a targets PRKCD in ACTH pituitary adenoma
E. Gentilin (Italy) |
| | | |
| 10:15 | OC4.4 OC4.4 | Identification of coupling specificity between somatostatin receptor 5 (SST5) and G proteins by a bioluminescence resonance energy transfer (BRET) technique: the role of GoA protein
E. Peverelli (Italy) |
| | | |
| 10:30 | OC4.5 OC4.5 | Targeting the IGF-IR system in pituitary tumors in vitro: antiproliferative action & pitfalls
M. Theodoropoulou (Germany) |
| | | |
| 10:45 | OC4.6 OC4.6 | Cell cycle G2/M transition is modulated by microRNAs in pituitary adenomas
H. Butz (Hungary) |
| | | |
| 09:30 11:00 | | Oral Communication 5 - Obesity Basic
Location: Hall E
Chairs: Chair(s): J. Gimble (USA) & S. Farooqi (UK)
|
| 09:30 | OC5.1 OC5.1 | Growth hormone ameliorates impaired glucose tolerance in obese mice by modifying the visceral fat condition through adiponectin
Y. Okamoto (Japan) |
| | | |
| 09:45 | OC5.2 OC5.2 | Production of galectin-1, -3, -9 and -12 in adipose tissue of lean and obese mice
G. Fantuzzi (United States) |
| | | |
| 10:00 | OC5.3 OC5.3 | Insulin action in brown adipose tissue is compromised during diet-induced obesity
C. Quarta (Italy) |
| | | |
| 10:15 | OC5.4 OC5.4 | Bile acid binding resin shows anti-obese effect through the modifications of intestinal microbiota
Y. Kusumoto (Japan) |
| | | |
| 10:30 | OC5.5 OC5.5 | Development of leptin deficient rat - evidence for its superiority over mouse as a model for human obesity
M. Aizawa-Abe (Japan) |
| | | |
| 10:45 | OC5.6 OC5.6 | Semaphorin 3C-a novel adipokine modulating human adipose tissue plasticity in weight change
M. Rydén (Sweden) |
| | | |
| 09:30 11:00 | | Oral Communication Session 6 - Female Reproduction Basic
Location: Hall F
Chairs: Chair(s): C. Elias (USA) & M. Simoni (Italy)
|
| 09:30 | OC6.1 OC6.1 | GnRH release failure in hyperprolactinemia is caused by a kisspeptin deficiency
N. Binart (France) |
| | | |
| 09:45 | OC6.2 OC6.2 | Ghrelin modulates fertilization, early embryo development and implantation
A. Martini (Argentina) |
| | | |
| 10:00 | OC6.3 OC6.3 | LH and hCG produce different responses in human granulosa lutein cells in vitro.
L. Casarini (Italy) |
| | | |
| 10:15 | OC6.4 OC6.4 | Female fertility and activin-stimulated Fshb expression do not require SMAD2/3 in murine gonadotropes
J. Fortin (Canada) |
| | | |
| 10:30 | OC6.5 OC6.5 | Dihydrotestosterone treatment in mice induces a persistent polycystic ovary syndrome phenotype
E. van Houten (The Netherlands) |
| | | |
| 10:45 | OC6.6 OC6.6 | Kit ligand-c-kit interaction regulates estradiol production by rat granulosa cells via oocyte factors
T. Miyoshi (Japan) |
| | | |
| 09:30 11:00 | | Oral Communication Session 7 - Adrenal Clinical
Location: Hall G
Chairs: Chair(s): B. Allolio (Germany) & J. Newell-Price (UK)
|
| 09:30 | OC7.1 OC7.1 | Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one year
S. Hescot (France) |
| | | |
| 09:45 | OC7.2 OC7.2 | Activation of the PKA pathway triggers formation of an illicit serotonergic regulatory loop in primary pigmented nodular adrenal disease (PPNAD) tissues associated with Cushing’s syndrome
Z. Bram (France) |
| | | |
| 10:00 | OC7.3 OC7.3 | Ribonucleotide reductase large subunit (RRM1) gene expression predicts efficacy of adjuvant mitotane in adrenocortical cancer
M. Volante (Italy) |
| | | |
| 10:15 | OC7.4 OC7.4 | Differential diagnosis of primary aldosteronism by peripheral plasma levels of 18-oxo-cortisol - a noninvasive method with a high specificity
F. Satoh (Japan) |
| | | |
| 10:30 | OC7.5 OC7.5 | Continuous subcutaneous hydrocortisone infusion as replacement therapy in Addison’s disease
M. Øksnes (Norway) |
| | | |
| 10:45 | OC7.6 OC7.6 | Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study
G. Di Dalmazi (Italy) |
| | | |
| 09:30 11:00 | | Oral Communication Session 8 - Bone
Location: Hall H
Chair: Chair(s): C. Marcocci (Italy)
|
| 09:30 | OC8.1 OC8.1 | Hypophosphatasia: Enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults
N. Kreher (USA) |
| | | |
| 09:45 | OC8.2 OC8.2 | Comparison of high protein and normal protein weight loss diets on bone density in overweight post-menopausal women
D. Jesudason (Australia) |
| | | |
| 10:00 | OC8.3 OC8.3 | Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts
A. Ferlin (Italy) |
| | | |
| 10:15 | OC8.4 OC8.4 | Radiological vertebral fractures in hospitalized elderly patients with heart failure
G. Mazziotti (Italy) |
| | | |
| 10:30 | OC8.5 OC8.5 | Pathogenetic chromosomal rearrangements in a large series of patients with pseudohypoparathyroidism type I
F. Marta Elli (Italy) |
| | | |
| 10:45 | OC8.6 OC8.6 | Simultaneous gain and loss of methylation at imprinted loci in a subset of patients with pseudohypoparathyroidism type 1b and GNAS epimutations
A. Linglart (France) |
| | | |
| 09:30 11:00 | | Oral Communication 9 - Endocrine Tumours & Translation
Location: Basilica
Chairs: Chair(s): K. Oberg (Sweden) & A. Grossman (UK)
|
| 09:30 | OC9.1 OC9.1 | Temozolomide therapy for progressive metastatic paraganglioma/pheochromocytoma: SDHB mutation as a prognosis biomarker for efficacy
J. Hadoux (France) |
| | | |
| 09:45 | OC9.2 OC9.2 | Growth hormone protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells
M. Minoia (Italy) |
| | | |
| 10:00 | OC9.3 OC9.3 | The central role of estrogen receptor α in IGF-II dependent adrenocortical carcinoma (ACC) cell proliferation suggests the use of selective estrogen receptor modulators (SERMs) for the treatment of ACC
V. Pezzi (Italy) |
| | | |
| 10:15 | OC9.4 OC9.4 | Functional characterization of mutations in the multiple endocrine neoplasia type 1 (MEN1) gene suggest therapeutic strategies
G. Hendy (Canada) |
| | | |
| 10:30 | OC9.5 OC9.5 | Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients
E. Christ (Switzerland) |
| | | |
| 10:45 | OC9.6 OC9.6 | First in vitro study of human gastroenteropancreatic-neuroendocrine tumors: Comparative effect of octreotide and pasireotide
A. Mohamed (France) |
| | | |
| 09:30 11:00 | | Endocrine Nurses' Session: Puberty Induction and Sex Steroid Replacement in Young Adults
Generously Supported By Novartis
Location: Polveriera
Chairs: Chair(s): J. Foote (USA) & P. Bouchard (France)
|
| 09:30 | EN1.1 EN1.1 | Puberty induction in males and females
C. Brain (UK) |
| | | |
| 10:00 | EN1.2 EN1.2 | The role of the endocrine nurse in puberty induction
M. Keil (USA) |
| | | |
| 10:15 | EN1.3 EN1.3 | Sex steroid replacement in young males and females
G. Conway (UK) |
| | | |
| 10:45 | EN1.4 EN1.4 | Choosing the right sex steroid replacement option for patients: the role of the endocrine nurse
S. Shalet (UK) |
| | | |
| 09:30 11:30 | | ISE General Council Meeting (Invitation Only)
Location: Teatrino
|
| 11:00 11:30 | | Coffee, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 11:30 12:30 | | Debate 2: This house believes that calcium supplementation causes heart attacks
For: I. Reid (New Zealand); Against: C. Weaver (USA)
Location: Main Hall
Chair: Chair(s): J. Bollerslev (Norway)
|
| 11:30 13:15 | | ISE Travel Grant Reception (Invitation Only)
|
| 11:30 12:15 | | Meet the Expert 1 - Repeated
Location: Hall A
|
| 11:30 | MTE1 MTE1 | Adrenal incidentaloma and subclinical Cushing's syndrome
P. Stewart (UK) |
| | | |
| 11:30 12:15 | | Meet the Expert 2 - Repeated
Location: Hall B
|
| 11:30 | MTE2 MTE2 | Approach to the patient with Cushing's disease after pituitary surgery failure
M. Toth (Hungary) |
| | | |
| 11:30 12:15 | | Meet the Expert 3 - Repeated
Location: Hall C
|
| 11:30 | MTE3 MTE3 | Osteoporosis in men
U. Gruntmanis (USA) |
| | | |
| 11:30 12:15 | | Meet the Expert 4 - Repeated
Location: Hall D
|
| 11:30 | MTE4 MTE4 | Challenges of transsphenoidal pituitary surgery
P. Cappabianca (Italy) |
| | | |
| 11:30 12:15 | | Meet the Expert 5 - Repeated
Location: Hall E
|
| MTE5 MTE5 | Discussions of common but difficult thyroid cancer cases
L. Wartofsky (USA) |
| | | |
| 11:30 12:15 | | Meet the Expert 6 - Repeated
Location: Hall F
|
| 11:30 | MTE6 MTE6 | Clinical management of adrenocortical carcinoma
M. Terzolo (Italy) |
| | | |
| 11:30 12:15 | | Meet the Expert 7 - Repeated
Location: Hall G
|
| 11:30 | MTE7 MTE7 | Pregnancy and pituitary disorders
Z. Karaca (Turkey) |
| | | |
| 11:30 12:15 | | Meet the Expert 8 - Repeated
Location: Hall H
|
| 11:30 | MTE8 MTE8 | Diagnosis and treatment of precocious puberty
L. Ghizzoni (Italy) |
| | | |
| 12:25 13:10 | | Meet the Expert 9 - Repeated
Location: Hall A
|
| 12:25 | MTE9 MTE9 | Diagnosis and treatment of SIADH
C. Thompson (Ireland) |
| | | |
| 12:25 13:10 | | Meet the Expert 10 - Repeated
Location: Hall B
|
| 12:25 | MTE10 MTE10 | Elastosonography in the evaluation of thyroid and parathyroid lesions
M. Erdogan (Turkey) |
| | | |
| 12:25 13:10 | | Meet the Expert 11 - Repeated
Location: Hall C
|
| 12:25 | MTE11 MTE11 | Diagnosis and treatment considerations in autoimmune polyendocrine syndrome type 1
O. Kampe (Sweden) |
| | | |
| 12:25 13:10 | | Meet the Expert 12 - Repeated
Location: Hall D
|
| 12:25 | MTE12 MTE12 | Goitre throughout the paediatric ages
M. Polak (France) |
| | | |
| 12:25 13:10 | | Meet the Expert 13 - Repeated
Location: Hall E
|
| 12:25 | MTE13 MTE13 | Graves' ophthalmopathy
W. Wiersinga (The Netherlands) |
| | | |
| 12:25 13:10 | | Meet the Expert 14 - Repeated
Location: Hall F
|
| 12:25 | MTE14 MTE14 | Hirsutism
K. Unluhizarci (Turkey) |
| | | |
| 12:25 13:10 | | Meet the Expert 15 - Repeated
Location: Hall G
|
| 12:25 | MTE15 MTE15 | Pituitary tumours in adolescents and adults
M. Andersen (Denmark) |
| | | |
| 12:25 13:10 | | Meet the Expert 16 - Repeated
Location: Hall H
|
| 12:25 | MTE16 MTE16 | Management of non-functioning pituitary adenomas
N. Karavitaki (UK) |
| | | |
| 12:30 13:15 | | Lunch, Posters & Exhibition
ESE President meets ESE New Members (invitation only)
Exhibition Hall & Poster Hall
|
| 13:15 14:45 | | Symposium 26: TSH Receptor
Location: Hall A
Chairs: Chair(s): R. Paschke (Germany) & E. Martino (Italy)
|
| 13:15 | S26.1 S26.1 | Low-molecular weight antagonists of the TSH receptor
M. Gershengorn (USA) |
| | | |
| 13:45 | S26.2 S26.2 | Epitope geography and intracellular pathways of TSH receptor antibodies
T. Davis (USA) |
| | | |
| 14:15 | S26.3 S26.3 | Structure and function of TSH receptor
H. Biebermann (Germany) |
| | | |
| 13:15 14:45 | | Symposium 27: Are endogenous testosterone levels predictors of cardiovascular events?
Location: Hall B
Chairs: Chair(s): C. Wang (USA) & K. Channer (UK)
|
| 13:15 | S27.1 S27.1 | Androgen action on the cardiovascular system
K. Channer (UK) |
| | | |
| 13:45 | S27.2 S27.2 | Testosterone deficiency, cardiometabolic and mortality risks in men: the European Male Ageing Study (EMAS)
F. Wu (UK) |
| | | |
| 14:15 | S27.3 S27.3 | Endogenous androgens, diabetes, and cardiovascular disease in women: The rancho bernado study
E. Barrett-Connor (USA) |
| | | |
| 13:15 14:45 | | Symposium 28: Osteoporosis treatment in 2012 and beyond
Location: Hall C
Chairs: Chair(s): G. Borretta (Italy) & J. Stepan (Czech Republic)
|
| 13:15 | S28.1 S28.1 | Controversial issues with bisphosphonate treatment
S. Papapoulos (The Netherlands) |
| | | |
| 13:45 | S28.2 S28.2 | Sclerostin - a key bone regulatory molecule
M. Robinson (USA) |
| | | |
| 14:15 | S28.3 S28.3 | Other emerging therapies
P. Ebeling (Australia) |
| | | |
| 13:15 14:45 | | Symposium 29: Are we ready for novel therapies in obesity?
Location: Hall D
Chairs: Chair(s): F. Giorgino (Italy) & U. Pagotto (Italy)
|
| 13:15 | S29.1 S29.1 | GI Hormone-based polypharmacy for the treatment of obesity
M. Tschoep (Germany) |
| | | |
| 13:45 | S29.2 S29.2 | Growth hormone replacement and metabolic syndrome in GH deficient adults
D. Clemmons (USA) |
| | | |
| 14:15 | S29.3 S29.3 | The ghrelin-GOAT system links dietary lipids with the endocrine control of energy balance
P. Pfluger (Germany) |
| | | |
| 13:15 14:45 | | Symposium 30: New developments in pituitary adenomas
Location: Hall E
Chairs: Chair(s): G. Raverot (France) & G. Lombardi (Italy)
|
| 13:15 | S30.1 S30.1 | New developments in pituitary adenoma cytokines & other new genes in pituitary adenomas
E. Arzt (Argentina) |
| | | |
| 13:45 | S30.2 S30.2 | 'Dopastatin': an evolving story
T. Brue (France) |
| | | |
| 14:15 | S30.3 S30.3 | The use of temozolomide in pituitary tumours
A. McCormack (Australia) |
| | | |
| 13:15 14:45 | | Symposium 31: Progress in treatment in primary aldosteronism
Location: Hall F
Chairs: Chair(s): J. Widimsky (Czech Republic) & P. Mulatero (Italy)
|
| 13:15 | S31.1 S31.1 | Epidemiology and diagnosis of primary aldosteronism
P-F. Plouin (France) |
| | | |
| 13:45 | S31.2 S31.2 | Surgery
M. Walz (Germany) |
| | | |
| 14:15 | S31.3 S31.3 | Medical treatment
L. Sechi (Italy) |
| | | |
| 13:15 14:45 | | Symposium 32: Disorders of sex development (DSD)
Location: G
Chairs: Chair(s): P. Lee (USA) & P. Cohen-Kettenis (The Netherlands)
|
| 13:15 | S32.1 S32.1 | Genetics of disorders of sex development
T. Ogata (Japan) |
| | | |
| 13:45 | S32.2 S32.2 | Psychosocial and psychosexual outcome in DSD
P. Cohen-Kettenis (The Netherlands) |
| | | |
| 14:15 | S32.3 S32.3 | Review of clinical guidelines
F. Ahmed (UK) |
| | | |
| 13:15 14:45 | | Symposium 33: Environment Induced Endocrine Disease
Location: Hall H
Chairs: Chair(s): M. Shupnik (USA) & J. Toppari (Finland)
|
| 13:15 | S33.1 S33.1 | Pollution related acromegaly
S. Cannavo (Italy) |
| | | |
| 13:45 | S33.2 S33.2 | Exposure to endocrine disrupting chemicals may interfere with reproductive development in humans and affect timing of puberty
K. Main (Denmark) |
| | | |
| 14:15 | S33.3 S33.3 | Effect of iodine intake on thyroid disease in China
W. Teng (China) |
| | | |
| 14:45 15:15 | | Coffee, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 15:15 16:45 | | Symposium 34: Effects of thyroid hormone derivatives
Location: Main Hall
Chairs: Chair(s): P. Laurberg (Denmark) & F. Monaco (Italy)
|
| 15:15 | S34.1 S34.1 | Pathways of thyroid hormone metabolism
J. Koehrle (Germany) |
| | | |
| 15:45 | S34.2 S34.2 | Thyroid hormone mimetic compounds
T. Scanlan (USA) |
| | | |
| 16:15 | S34.3 S34.3 | Trials of thyroid hormone analogues
P. Ladenson (USA) |
| | | |
| 15:15 16:45 | | Symposium 35: Endocrinology and the Olympics: Will hormones help to win?
Location: Hall A
Chairs: Chair(s): E. Ghigo (Italy) & R. Ross (UK)
|
| 15:15 | S35.1 S35.1 | Does the high performance athlete need hormone replacement?
L. Di Luigi (Italy) |
| | | |
| 15:45 | S35.2 S35.2 | Can an endocrine patient participate in high performance sports?
R. Auchus (USA) |
| | | |
| 16:15 | S35.3 S35.3 | Hormone abuse in sports: the knowns and unknowns
M. Thevis (Germany) |
| | | |
| 15:15 16:45 | | Symposium 36: Bone and metabolism
Location: Hall B
Chairs: Chair(s): J.Eisman (Australia) & J.J.Body (Belgium)
|
| 15:15 | S36.1 S36.1 | Leptin and bone signalling
S. Takeda (Japan) |
| | | |
| 15:45 | S36.2 S36.2 | Insulin bone axis
T. Clemens (USA) |
| | | |
| 16:15 | S36.3 S36.3 | Functions and mode of action of osteocalcin
G. Karsenty (USA) |
| | | |
| 15:15 16:45 | | Symposium 37: Diabetes and cancer
Location: Hall C
Chairs: Chair(s): L. Bach (Austria) & A. Abdel Raheem (Egypt)
|
| 15:15 | S37.1 S37.1 | Epidemiological evidence for a link between diabetes and cancer
A. Renehan (UK) |
| | | |
| 16:00 | S37.2 S37.2 | The role of the insulin receptor in cancer
A. Belfiore (Italy) |
| | | |
| 15:15 16:45 | | Symposium 38: Craniopharyngioma: Hypothalamic complications
Location: Hall D
Chairs: Chair(s): J. Hamilton (Canada) & M. Puig-Domingo (Spain)
|
| 15:15 | S38.1 S38.1 | Childhood craniopharyngioma
H. Müller (Germany) |
| | | |
| 15:45 | S38.2 S38.2 | Hypothalamic disorders in craniopharyngioma; relevance to clinical practice
C. Thompson (Ireland) |
| | | |
| 16:15 | S38.3 S38.3 | Management of hypothalamic obesity in patients with craniopharyngioma
G. Wittert (Australia) |
| | | |
| 15:15 16:45 | | Symposium 39: Adrenal insufficiency
Location: Hall E
Chairs: Chair(s): W. Arlt (UK) & C. Betterle (Italy)
|
| 15:15 | S39.1 S39.1 | Pathomechanism underlying adrenoleucodystrophy
G. Raymond (USA) |
| | | |
| 15:45 | S39.2 S39.2 | Molecular pathomechanisms of steroidogenetic adrenal disorders
F. Riepe (Germany) |
| | | |
| 16:15 | S39.3 S39.3 | New developments in the immunology of Addison's disease
E. Husebye (Norway) |
| | | |
| 15:15 16:45 | | Symposium 40: New familial endocrine cancer syndromes: pathophysiology and counselling
Location: Hall F
Chairs: Chair(s): E. Lalli (France) & D. Malkin (Canada)
|
| 15:15 | S40.1 S40.1 | DICER1 mutations characterize a novel syndrome with endocrine features
W. Foulkes (Canada) |
| | | |
| 15:45 | S40.2 S40.2 | The paediatric patient with paraganglioma syndrome
M. Robledo (Spain) |
| | | |
| 16:15 | S40.3 S40.3 | Li-Fraumeni syndrome: A paradigm of genetic testing to clinical surveillance for pediatric endocrine tumors
D. Malkin (Canada) |
| | | |
| 15:15 16:45 | | Symposium 41: The endocrinology of adipose tissue
Location: Hall G
Chair: Chair(s): M. Luconi (Italy)
|
| 15:15 | S41.1 S41.1 | Physiological and neuronal determinants of brown adipose tissue-mediated thermogenesis in small mammals and humans
D. Richard (Canada) |
| | | |
| 15:45 | S41.2 S41.2 | Obesity and insulin resistance: the cross-talk macrophage-adipocyte view
J. Fernandez-Real (Spain) |
| | | |
| 16:15 | S41.3 S41.3 | The fat cell: dynamics, genomics and adipokines
P. Arner (Sweden) |
| | | |
| 15:15 16:45 | | Symposium 42: Novel insights into regulation of puberty
Location: Hall H
Chairs: Chair(s): E. Malecka-Tendera (Poland) & M. Cappa (Italy)
|
| 15:15 | S42.1 S42.1 | Central networks controlling the timing of puberty
A. Lomniczi (USA) |
| | | |
| 15:45 | S42.2 S42.2 | Re-wiring the hypothalamus with new peptides to control puberty
V. Navarro (USA) |
| | | |
| 16:15 | S42.3 S42.3 | Novel insights into regulation of puberty: lessons from human genetics
B. Mendonca (Brazil) |
| | | |
| 16:35 17:10 | | JOE / JME Prize Presentation
Location: Main Hall
Chair: Chair(s): A. Clark (UK)
|
| 17:10 17:55 | | Fondation IPSEN 2012 Endocrine Regulation Prize
Location: Main Hall
|
| 17:10 | IFPL1 IFPL1 | Wylie Vale Endocrine Prize Lecture at the 2012 ICE/ECE Congress
P. Sassone Corsi (USA) |
| | | |
| 17:55 19:30 | | Poster Reception
Attended poster session, refreshments available
Poster Hall
|
| 18:30 20:00 | | IPSEN Satellite Symposia - Acromegaly: patient-focused disease control and long-term outcomes
Location: Hall B
|
| 18:30 | | Welcome
E. Ghigo (Italy) |
| | | |
| 18:35 | | Biochemical determinants of long-term outcomes
S. Lamberts (The Netherlands) |
| | | |
| 18:55 | | Clinical determinants of long-term outcomes
A. Giustina (Italy) |
| | | |
| 19:15 | | Therapeutic determinants of long-term outcomes
M. Gadelha (Brazil) |
| | | |
| 19:35 | | Economic burden of long-term acromegaly management
S. Melmed (USA) |
| | | |
| 19:55 | | Summary and close
S. Melmed (USA) |
| | | |
| 18:30 20:00 | | NOVARTIS Satellite Symposia - Taking the next step: improving outcomes in patients with pituitary tumors
Location: Main Hall
Chair: A-M. Colao (Italy)
|
| 18:30 | | Welcome and Introduction
A-M. Colao (Italy) |
| | | |
| 18:35 | | Advancing the partnership: A multidisciplinary approach to treating Cushing's disease
P. Cappabianca (Italy) |
| | | |
| 18:50 | | Walking in their shoes: Case studies of Cushing's disease
I. Shimon (Israel) |
| | | |
| 19:05 | | Toeing the line: Criteria for and achievement of control in acromegaly
J. Wass (UK) |
| | | |
| 19:20 | | Striding towards the future: Somatostatin analogues for acromegaly
A-M. Colao (Italy) |
| | | |
| 19:40 | | Panel discussion
A-M. Colao (Italy), P. Cappabiance (Italy), I. Shimon (Israel), J. Wass (UK)
|
| | | |
| 19:55 | | Concluding remarks
A-M. Colao (Italy) |
| | | |
| 18:30 20:00 | | PROSTRAKAN Satellite Symposia - Testosterone replacement therapy - benefits & risks?
Location: Hall F
Chair: M. Maggi
|
| 18:30 | | Welcome, Opening Remarks & Introduction
M. Maggi (Florence, Italy) |
| | | |
| 18:35 | | Testosterone - emerging data for the management of hypogonadel men with Type 2 diabetes
H. Jones (Barnsley, UK) |
| | | |
| 19:00 | | Testosterone - emerging data for the management of hypogonadel men with heart disease
K. Channer (Sheffield, UK) |
| | | |
| 19:25 | | Testosterone replacement therapy and prostate diseases
M. Maggi (Florence, Italy) |
| | | |
| 19:50 | | Q&A and Chairman's Concluding Comments
|
| | | |
| 20:30 21:15 | | ICE/ECE 2012 Congress Concert
Tickets should be purchased during registration
Basilica di San Lorenzo
|
| 8 May 2012 |
| 07:00 20:00 | | Registration
|
| 07:00 08:30 | | Industry Sponsored Satellite Symposia
|
| 08:30 09:15 | | Plenary Lecture 4
Location: Main Hall
Chair: Chair(s): P. Bouchard (France)
|
| 08:30 | PL4 PL4 | Cushing Syndrome: Minnie G. and the Next 100 Years
A lecture given by the Endocrine Society President-Elect
W. Young (USA) |
| | | |
| 09:30 11:00 | | Oral Communication Session 10 - Pituitary Clinical 2
Location: Hall A
Chairs: Chair(s): J. Christiansen (Denmark) & A. Peri (Italy)
|
| 09:30 | OC10.1 OC10.1 | Predictors of morbidity and mortality in acromegaly: an Italian survey on behalf of the Italian Study Group of Acromegaly
M. Arosio (Italy) |
| | | |
| 09:45 | OC10.2 OC10.2 | Food intake regulating hormones in adult craniopharyngioma patients
J. Roemmler (Germany) |
| | | |
| 10:00 | OC10.3 OC10.3 | Pathophysiology of renal calcium handling in acromegaly revisited
P. Kamenicky (France) |
| | | |
| 10:15 | OC10.4 OC10.4 | Higher glucocorticoid supplementation doses are associated with increased overall mortality in patients with non-functioning pituitary adenoma
T. Zueger (Switzerland) |
| | | |
| 10:30 | OC10.5 OC10.5 | Once-Weekly, CTP-modified hGH (MOD-4023) is Effective in Growth Hormone Deficient Adults: A Phase II, Dose and Frequency Finding Study
V. Popovic (Serbia) |
| | | |
| 10:45 | OC10.6 OC10.6 | Second neoplasms in childhood cancer survivors with growth hormone deficiency treated or not treated with GH
F. Felicetti (Italy) |
| | | |
| 09:30 11:00 | | Oral Communication Session 11 - Thyroid Clinical 2
Location: Hall B
Chairs: Chair(s): L. Hegedus (Denmark) & C. Chang (Taiwan)
|
| 09:30 | OC11.1 OC11.1 | Growth retardation and severe constipation due to the first human, dominant negative thyroid hormone receptor alpha mutation
N. Schoenmakers (UK) |
| | | |
| 09:45 | OC11.2 OC11.2 | Subclinical thyroid disease and risk of new-onset atrial fibrillation
C. Selmer (Denmark) |
| | | |
| 10:00 | OC11.3 OC11.3 | Is overt hypothyroidism associated with increased mortality? A nationwide register-based study of disease discordant Danish twins
M. Thvilum (Denmark) |
| | | |
| 10:15 | OC11.4 OC11.4 | The frequency of TSH receptor mutation and clinical characteristics among 84 patients with hyperthyroidism with diffuse goiter and negative TBII
E. Nishihara (Japan) |
| | | |
| 10:30 | OC11.5 OC11.5 | Thyroid hormones and male sexual function
G. Corona (Italy) |
| | | |
| 10:45 | OC11.6 OC11.6 | Is age a risk factor for hypothyroidism in pregnancy? An analysis of 5223 pregnant women
E. Potlukova (Czech Republic) |
| | | |
| 09:30 11:00 | | Oral Communication Session 12 - Obesity Clinical
Location: Hall C
Chairs: Chair(s): J. Tomlinson (UK) & M. Bielhouby (Germany)
|
| 09:30 | OC12.1 OC12.1 | Circulating endocannabinoids are associated to cardiometabolic alterations independently from adiposity
F. Fanelli (Italy) |
| | | |
| 09:45 | OC12.2 OC12.2 | Lipid-induced insulin resistance is associated with a reduction of IGF-I bioactivity independent of changes in IGFBP-1 and -2 in humans
A. Arafat (Germany) |
| | | |
| 10:00 | OC12.3 OC12.3 | Transient increase of beta-cell first phase secretion after smoking cessation - a possible contributor to carbohydrate craving and body weight gain?
M. Stadler (Austria) |
| | | |
| 10:15 | OC12.4 OC12.4 | Genetic susceptibility, birth weight and obesity risk in young Chinese
J. Hong (China) |
| | | |
| 10:30 | OC12.5 OC12.5 | Brown adipose tissue activation is inversely related with central obesity and metabolic parameters in adult human
W. Wang (China) |
| | | |
| 10:45 | OC12.6 OC12.6 | Eating speed and the risk of type 2 diabetes mellitus: a case-control study
L. Radzeviciene (Lithuania) |
| | | |
| 09:30 11:00 | | Oral Communication Session 13 - Adrenal Basic
Location: Hall D
Chairs: Chair(s): M-C. Zennaro (France) & S. Hahner (Germany)
|
| 09:30 | OC13.1 OC13.1 | Targeting multiple signalling pathways showed high anti-tumour potential in two mouse phaeochromocytoma cell lines
S. Nölting (UK) |
| | | |
| 09:45 | OC13.2 OC13.2 | VSNL1 is upregulated in aldosterone producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis
S. Monticone (Italy) |
| | | |
| 10:00 | OC13.3 OC13.3 | Cortisol secretion is dependent on intraadrenal production of ACTH in macronodular bilateral adrenal hyperplasia causing Cushing's syndrome
E. Louiset (France) |
| | | |
| 10:15 | OC13.4 OC13.4 | A genome-wide methylation study of adrenocortical tumors shows specific alterations linked to gene expression, revealing new aspects of the molecular classification of adrenal carcinomas
G. Assié (France) |
| | | |
| 10:30 | OC13.5 OC13.5 | KCNJ5 mutations in Japanese patients with aldosterone-producing adenomas
M. Yamada (Japan) |
| | | |
| 10:45 | OC13.6 OC13.6 | GATA-4 overexpression induces adrenocortical tumorigenesis and ectopic expression of luteinizing hormone receptor in C57Bl/6J mice
M. Chrusciel (Finland) |
| | | |
| 09:30 11:00 | | Oral Communication Session 14 - Male Reproduction
Location: Hall E
Chairs: Chair(s): R. Swerdloff (USA) & C. Krausz
|
| 09:30 | OC14.1 OC14.1 | X chromosome-linked copy number variations in male infertility
C. Krausz (Italy) |
| | | |
| 09:45 | OC14.2 OC14.2 | Deficient expression of genes involved in the endogenous defense system against transposons in cryptorchid boys with impaired mini-puberty
F. Hadziselimovic (Switzerland) |
| | | |
| 10:00 | OC14.3 OC14.3 | Comparison of serum testosterone and estradiol levels in 3174 European men as measured by a platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men
I. Huhtaniemi (UK) |
| | | |
| 10:15 | OC14.4 OC14.4 | The prevalence of hypogonadism in men on methadone maintenance.
A. McGowan (Ireland) |
| | | |
| 10:30 | OC14.5 OC14.5 | The Muenster EXAKT project: X-inactivation in Klinefelter patients
S. Werler (Germany) |
| | | |
| 10:45 | OC14.6 OC14.6 | Erectile dysfunction after liver transplantation
O. Levalle (Argentina) |
| | | |
| 09:30 11:00 | | Oral Communication Session 15 - Thyroid Basic
Location: Hall F
Chairs: Chair(s): L. Fugazzola (Italy) & S Gullu (Turkey)
|
| 09:30 | OC15.1 OC15.1 | PATZ1 is a new candidate tumour-suppressor gene in thyroid cancer
M. Fedele (Italy) |
| | | |
| 09:45 | OC15.2 OC15.2 | Ligand bound-thyroid hormone receptor contributes to reprogramming of pancreatic exocrine cells to insulin-producing cells via induction of Ngn3 and MafA
F. Furuya (Japan) |
| | | |
| 10:00 | OC15.3 OC15.3 | Radioiodine therapy of non-thyroidal cancer following systemic sodium iodide symporter (NIS) gene transfer using Transferrin-receptor (Tfr) targeted non-viral gene delivery vectors
M. J Willhauck (Germany) |
| | | |
| 10:15 | OC15.4 OC15.4 | The DNA methylation as a predisposition factor in the pathogenesis of congenital hypothyroidism in premature infants
F. Marelli (Italy) |
| | | |
| 10:30 | OC15.5 OC15.5 | Lymphatic endothelial markers podoplanin and PROX1 in differentiated thyroid tumours
J. Janik (Poland) |
| | | |
| 10:45 | OC15.6 OC15.6 | Thyroglobulin induces thyroid cell growth through suppression of miR-16 and miR-195
T. Akama (Japan) |
| | | |
| 09:30 11:00 | | Oral Communication Session 16 - Female Reproduction Clinical
Location: Hall G
Chairs: Chair(s): T. Sir-Petermann (Chile) & A. Gambineri (Italy)
|
| 09:30 | OC16.1 OC16.1 | The association between birth weight and PCOS in adult life. A register-based study on 523,757 Danish women born 1973-1991
H. Mumm (Denmark) |
| | | |
| 09:45 | OC16.2 OC16.2 | The first missense mutation of BMP15 mature domain identified in a Chinese family with primary ovarian insufficiency causes defective production of the bioactive protein
R. Rossetti (Italy) |
| | | |
| 10:00 | OC16.3 OC16.3 | Anti-muellerian hormone as a predictor of ovarian response to weight loss in overweight women with polycystic ovary syndrome
P. Popova (Russia) |
| | | |
| 10:15 | OC16.4 OC16.4 | Epidemiological survey on the prevalence of hyperandrogenic states in adolescent and young women
A. Gambineri (Italy) |
| | | |
| 10:30 | OC16.5 OC16.5 | Urinary glucocorticoid metabolite excretion is associated with insulin resistance independent of body mass index (BMI) in patients with polycystic ovary syndrome
M. O'Reilly (UK) |
| | | |
| 10:45 | OC16.6 OC16.6 | Kisspeptin-10 stimulation of gonadotropin secretion in women is modulated by sex steroid feedback
J. George (UK) |
| | | |
| 09:30 11:00 | | Oral Communication 17 - Diabetes Basic
Location: Hall H
Chairs: Chair(s): A. Belfiore (Italy) & S. Assaad (Egypt)
|
| 09:30 | OC17.1 OC17.1 | Pdk1/Foxo1 pathway regulates macrophage migration, polarization, and insulin sensitivity
Y. Kawano (Japan) |
| | | |
| 09:45 | OC17.2 OC17.2 | Placental restriction co-ordinately alters hepatic expression of microRNAs and targets related to non alcoholic fatty liver disease, in adult male sheep
J. Owens (Australia) |
| | | |
| 10:00 | OC17.3 OC17.3 | Caerulin Precursor Fragment (CPF-AM1): A novel insulinotropic peptide from the skin secretion of the clawed frog, Xenopus amieti
O. Ojo (UK) |
| | | |
| 10:15 | OC17.4 OC17.4 | Syntaxin-3 regulates recruitment and exocytosis of newcomer insulin granules and granule-granule fusion during biphasic glucose-stimulated insulin secretion in pancreatic β-cells
H. Gaisano (Canada) |
| | | |
| 10:30 | OC17.5 OC17.5 | Glucocorticoid receptor alpha expression is downregulated in gluteal subcutaneous adipose tissue of black south african women and associates with increased metabolic risk
J. Goedecke (South Africa) |
| | | |
| 10:45 | OC17.6 OC17.6 | Meta-analysis of differentially expressed microRNAs in type 1, type 2 and gestational diabetes mellitus
E. Donadi (Brazil) |
| | | |
| 09:30 11:00 | | Oral Communication 18 - Paediatric Endocrinology
Location: Teatrino
Chairs: Chair(s): R. Voutilainen (Finland) & C. Deal (Canada)
|
| 09:30 | OC18.1 OC18.1 | Mutations in the NR5A1 gene in patients with 46,XY disorders of sex development (DSD): High frequency of familial multi-generational occurrence
M. Costanzo (Argentina) |
| | | |
| 09:45 | OC18.2 OC18.2 | Clinical profile, gender choice and long term follow up of subjects with 5 alpha-steroid reductase 2 deficiency
A. Ammini (India) |
| | | |
| 10:00 | OC18.3 OC18.3 | Effects of vitamin D insufficiency and its correction on insulin sensitivity and serum osteocalcin concentration in obese children
P. Nantarakchaikul (Thailand) |
| | | |
| 10:15 | OC18.4 OC18.4 | Mortality in GH-treated (Tx) patients enrolled in the global Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)
C. Child (UK) |
| | | |
| 10:30 | OC18.5 OC18.5 | Earlier reactivation of the hypothalamo-pituitary-gonadal axis and advancement of puberty in boys under labour stress
A. Naseem (Pakistan) |
| | | |
| 10:45 | OC18.6 OC18.6 | Functional characterization of a new mutation in the NKX2.1 in patients with thyroid-lung-brain syndrome
I. Nettore (Italy) |
| | | |
| 09:30 11:00 | | Oral Communicatin Session 19 - Cardiovascular Endocrinology
Location: Basilica
Chairs: Chair(s): M. Alevizaki (Greece) & H. Romjin (The Netherlands)
|
| 09:30 | OC19.1 OC19.1 | Both EPA/AA ratio and absolute AA levels constitute an independent risk factor for coronary atherosclerosis in type 2 diabetic patients
T. Nakamua (Japan) |
| | | |
| 09:45 | OC19.2 OC19.2 | Increased arterial stiffness is independently associated with cerebral infarctions and white matter lesions in patients with type 2 diabetes despite good blood pressure and lipid control
E. Laugesen (Denmark) |
| | | |
| 10:00 | OC19.3 OC19.3 | Copeptin and adrenomedullin in a large cohort of patients with coronary heart disease and newly diagnosed glucose intolerance (“Silent diabetes study”)
T. Lohmann (Germany) |
| | | |
| 10:15 | OC19.4 OC19.4 | Oxytocin is cardioprotective hormone
J. Gutkowska (Canada) |
| | | |
| 10:30 | OC19.5 OC19.5 | Circulating adrenomedulin levels are associated with atrial natriuretic peptide and brain natriuretic peptide levels in heart failure patients
P. Holmager (Denmark) |
| | | |
| 10:45 | OC19.6 OC19.6 | Endothelial progenitor cells in acromegaly are reduced and responsive to treatmet with somatostatin analogues
P. Maffei (Italy) |
| | | |
| 09:30 11:00 | | Endocrine Nurses' Session: Cushing's and Prolactinoma - diagnosis and management
Polveriera
Chairs: Chair(s): M. Valota, Italy & P. Burman, Sweden
|
| 09:30 | EN2.1 EN2.1 | Diagnosis and management of cushing's syndrome
R. Feelders (The Netherlands) |
| | | |
| 10:00 | EN2.2 EN2.2 | The role of the endocrine nurse in the diagnosis and management of the patient with cushing's syndrome
W. Geilvoet (The Netherlands) |
| | | |
| 10:15 | EN2.3 EN2.3 | Diagnosis and management of prolactinoma
M. Andersen (Denmark) |
| | | |
| 10:45 | EN2.4 EN2.4 | The role of the endocrine nurse in the diagnosis and management of the patient with prolactinoma
A. Marland (UK) |
| | | |
| 11:00 11:30 | | Coffee, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 11:30 12:30 | | Debate 3: This house believes that PCOS needs a new name
For: H. Teede (Australia); Against: D. Dewailly (France)
Location: Main Hall
Chair: Chair(s): A. Dunaif (USA)
|
| 11:30 12:15 | | Meet the Expert 17
Location: Hall A
|
| 11:30 | MTE17 MTE17 | Multiple endocrine neoplasia type II
F. Raue (Germany) |
| | | |
| 11:30 12:15 | | Meet the Expert 18
Location: Hall B
|
| 11:30 | MTE18 MTE18 | Normocalcemic primary hyperparathyroidism
C. Marcocci (Italy) |
| | | |
| 11:30 12:15 | | Meet the Expert 19
Location: Hall C
|
| 11:30 | MTE19 MTE19 | Maturity onset diabetes of the young
A. Hattersley (UK) |
| | | |
| 11:30 12:15 | | Meet the Expert 20
Location: Hall D
|
| 11:30 | MTE20 MTE20 | The diagnosis and treatment of secondary osteoporosis in children
L. Ward (USA) |
| | | |
| 11:30 12:15 | | Meet the Expert 21
Location: Hall E
|
| 11:30 | MTE21 MTE21 | Autoimmune hyperthyroidism: Initiation and duration of thionamide therapy
P. Laurberg (Denmark) |
| | | |
| 11:30 12:15 | | Meet the Expert 22
Location:Hall F
|
| 11:30 | MTE22 MTE22 | Clinical management in transgender sex hormone treatment
G. T'Sjoen (Belgium) |
| | | |
| 11:30 12:15 | | Meet the Expert 23
Location: Hall G
|
| 11:30 | MTE23 MTE23 | Subclinical hypothyroidism
B. Biondi (Italy) |
| | | |
| 11:30 12:15 | | Meet the Expert 24
Location: Hall H
|
| 11:30 | MTE24 MTE24 | Approach to the management of the infertile couple
A. Lenzi (Italy) |
| | | |
| 12:25 13:10 | | Meet the Expert 25
Location: Hall A
|
| 12:25 | MTE25 MTE25 | Pituitary incidentalomas
S. Tsagarakis (Greece) |
| | | |
| 12:25 13:10 | | Meet the Expert 26
Location: Hall B
|
| 12:25 | MTE26 MTE26 | PCOS
E. Diamanti-Kandarakis (Greece) |
| | | |
| 12:25 13:10 | | Meet the Expert 27
Location: Hall C
|
| 12:25 | MTE27 MTE27 | Differential diagnosis of Cushing's syndrome
J. Salvador (Spain) |
| | | |
| 12:25 13:10 | | Meet the Expert 28
Location: Hall D
|
| 12:25 | MTE28 MTE28 | Hypoglycaemia and diabetes management
W. Sheu (Taiwan) |
| | | |
| 12:25 13:10 | | Meet the Expert 29
Location: Hall E
|
| 12:25 | MTE29 MTE29 | Management of bone loss induced by cancer treatment in early breast and prostate cancer
J. Body (Belgium) |
| | | |
| 12:25 13:10 | | Meet the Expert 30
Location: Hall F
|
| 12:25 | MTE30 MTE30 | Treatment of vitamin D deficiency
N. Tandon (India) |
| | | |
| 12:25 13:10 | | Meet the Expert 31
Location: Hall G
|
| 12:25 | MTE31 MTE31 | Cryptorchidism
J. Toppari (Finland) |
| | | |
| 12:25 13:10 | | Meet the Expert 32
Location: Hall H
|
| 12:25 | MTE32 MTE32 | Management of GEP-NET tumours
K. Oberg (Sweden) |
| | | |
| 12:30 13:15 | | Lunch, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 12:30 13:15 | | ESE Annual General Meeting
ESE Members Only - Lunch Provided
Teatrino
|
| 13:15 14:45 | | Symposium 43: Graves' orbitopathy (GO)
Location: Hall A
Chairs: Chair(s): A. Karlsson (Sweden) & W. Wiersinga (The Netherlands)
|
| 13:15 | S43.1 S43.1 | Immunopathogenesis of Graves' orbitopathy
R. Bahn (USA) |
| | | |
| 13:45 | S43.2 S43.2 | How to restore euthyroidism in the presence of Graves’ orbitopathy? Is there a best way?
L. Hegedus (Denmark) |
| | | |
| 14:15 | S43.3 S43.3 | Progress in immunosuppressive treatment of GO (selenium, steroid dosage, rituximab)
L. Bartalena (Italy) |
| | | |
| 13:15 14:45 | | Symposium 44: Genome wide studies in reproduction
Location: Hall B
Chairs: Chair(s): M. Urbanek (USA) & J. Laven (The Netherlands)
|
| 13:15 | S44.1 S44.1 | Genome-wide association study of endometriosis identifies a locus at 7p15.2 with pleiotropic effects
K. Zondervan (UK) |
| | | |
| 13:45 | S44.2 S44.2 | Genetic studies on polycystic ovary syndrome
Z-J. Chen (China) |
| | | |
| 14:15 | S44.3 S44.3 | Genetics of (in)fertility
J. Laven (Netherlands) |
| | | |
| 13:15 14:45 | | Symposium 45: Bone quality and bone strength
Location: Hall C
Chairs: Chair(s): E. Seeman (Australia) & M. Brandi (Italy)
|
| 13:15 | S45.1 S45.1 | Bone quality and micro architecture
R. Rizzoli (Switzerland) |
| | | |
| 13:45 | S45.2 S45.2 | Finite element analysis in osteology
P. Zysset (Austria) |
| | | |
| 14:15 | S45.3 S45.3 | Non-invasive assessment of bone mass by various modalities
R. Prince (Australia) |
| | | |
| 13:15 14:45 | | Symposium 46: Chronic inflammation and insulin resistance
Location: Hall D
Chairs: Chair(s): E. Bonora (Italy) & P. Scherer (USA)
|
| 13:15 | S46.1 S46.1 | AIMing at Metabolic Syndrome: Towards development of novel therapies for modern metabolic diseases via macrophage-derived AIM
T. Miyazaki (Japan) |
| | | |
| 13:45 | S46.2 S46.2 | Macrophage regulation of adipocyte biology
P. Scherer (USA) |
| | | |
| 14:15 | S46.3 S46.3 | The inflammatory-adipokine hypothesis and stem cell abnormalities
R. Vettor (Italy) |
| | | |
| 13:15 14:45 | | Symposium 47: Cushing's syndrome
Location: Main Hall
Chairs: Chair(s): N. Shah (India) & L. Nieman (USA)
|
| 13:15 | S47.1 S47.1 | Long term sequelae of 'cured' Cushing's syndrome
J. Newell-Price (UK) |
| | | |
| 13:45 | S47.2 S47.2 | Established and new medical treatment options for Cushing's disease
A. Tabarin (France) |
| | | |
| 14:15 | S47.3 S47.3 | Learnings from ERCUSYN: The first 500 patients
E. Valassi (Spain) |
| | | |
| 13:15 14:45 | | Symposium 48: Pathogenesis of primary aldosteronism
Location: Hall E
Chairs: Chair(s): F. Mantero (Italy) & W. Rainey (USA)
|
| 13:15 | S48.1 S48.1 | Genomic profile in primary aldosteronism
P. Hellman (Sweden) |
| | | |
| 13:45 | S48.2 S48.2 | Integrating genetics and genomics in primary aldosteronism
M.C. Zennaro (France) |
| | | |
| 14:15 | S48.3 S48.3 | Potassium channels in primary aldosteronism
R. Warth (Germany) |
| | | |
| 13:15 14:45 | | Symposium 49: Genetic breakthroughs in reproductive pathology and physiology
Location: Hall F
Chairs: Chair(s): J. Young (France) & P. Beck-Peccoz (Italy)
|
| 13:15 | S49.1 S49.1 | New mechanisms of hypothalamic amenorrhea
N. Pitteloud (Switzerland) |
| | | |
| 14:00 | S49.3 S49.3 | RANK ligand mediates hormone induced mammary epithelial proliferation and carcinogenesis
E. Gonzalez-Suarez (Spain) |
| | | |
| 13:15 14:45 | | Symposium 50: Circadian regulation of metabolism
Location: Hall G
Chairs: Chair(s): J. Klein (Germany) & E. van Cauter (USA)
|
| 13:15 | S50.1 S50.1 | Basic mechanisms of circadian regulation in the brain
H. Oster (Germany) |
| | | |
| 13:45 | S50.2 S50.2 | Metabolic dysfunction: impact of circadian and sleep regulation
E. van Cauter (USA) |
| | | |
| 14:15 | S50.3 S50.3 | Circadian rhythms in adipose tissue
J. Gimble (USA) |
| | | |
| 13:15 14:45 | | Symposium 51: Recent management of pheochromocytoma / paraganglioma syndrome
Location: Hall H
Chairs: Chair(s): M. Mannelli (Italy) & Z-P. Zeng (China)
|
| 13:15 | S51.1 S51.1 | Recent progress in biochemical testing for pheochromocytoma
S. Petersenn (Germany) |
| | | |
| 13:45 | S51.2 S51.2 | Prevalence of SDH gene mutations in pheochromocytoma
G. Opocher (Italy) |
| | | |
| 14:15 | S51.3 S51.3 | Treatment of malignant pheochromocytoma
A. Tanabe (Japan) |
| | | |
| 14:45 15:15 | | Coffee, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 15:15 16:45 | | Symposium 52: Thyroid & pregnancy
Location: Main Hall
Chairs: Chair(s): K. Poppe (Belgium) & A. Pinchera (Italy)
|
| 15:15 | S52.1 S52.1 | Outcome of the Controlled Antenatal Thyroid Screening Study (CATS) study
J. Lazarus (UK) |
| | | |
| 15:45 | S52.2 S52.2 | The case for thyroid screen in pregnancy
R. Negro (Italy) |
| | | |
| 16:15 | S52.3 S52.3 | Challenges with diagnosis and treatment of hyperthyroidism in pregnancy
F. Azizi (Iran) |
| | | |
| 15:15 16:45 | | Symposium 53: Genetic polymorphism in reproduction
Location: Hall A
Chairs: Chair(s): C. Krausz (Italy) & A. Latronico (Brazil)
|
| 15:15 | S53.1 S53.1 | Genetic variation of the androgen receptor: from gene regulation to prostate cancer
M. Zitzmann (Germany) |
| | | |
| 15:45 | S53.2 S53.2 | Gene polymorphisms and male infertility
S. Repping (The Netherlands) |
| | | |
| 16:15 | S53.3 S53.3 | Genetic complexity of FSH reception function
M. Simoni (Italy) |
| | | |
| 15:15 16:45 | | Symposium 54: Vitamin D
Location: Hall B
Chairs: Chair(s): P. Lips (The Netherlands) & R. Bouillon (Belgium)
|
| 15:15 | S54.1 S54.1 | Vitamin D is a multifunctional hormone
R. Bouillon (Belgium) |
| | | |
| 15:45 | S54.2 S54.2 | Vitamin D and primary hyperparathyroidism
L. Mosekilde (Denmark) |
| | | |
| 16:15 | S54.3 S54.3 | Vitamin D and falls
H. Bischoff-Ferrari (USA) |
| | | |
| 15:15 16:45 | | Symposium 55: The fatty liver as an endocrine disease
Location: Hall C
Chairs: Chair(s): J. Tomlinson (UK) & M. Tschoep (Germany)
|
| 15:15 | S55.1 S55.1 | Pathogenesis of fatty liver disease
C. Postic (France) |
| | | |
| 15:45 | S55.2 S55.2 | Insulin sensitizer treatment of fatty liver disease
K. Cusi (USA) |
| | | |
| 16:15 | S55.3 S55.3 | Fatty liver disease in childhood
V. Nobili (Italy) |
| | | |
| 15:15 16:45 | | Symposium 56: Pituitary development transcription factors: stem cells and beyond
Location: Hall D
Chairs: Chair(s): M. Dattani (UK) & C. Bousquet (France)
|
| 15:15 | S56.1 S56.1 | The GPS niche of stem cells in the pituitary
C.V. Alvarez (Spain) |
| | | |
| 15:45 | S56.2 S56.2 | LHX3: An insightful model of pituitary hormone deficiency
S. Rhodes (USA) |
| | | |
| 16:15 | S56.3 S56.3 | Transcriptional and epigenetic mechanisms for cell fate choice in pituitary
J. Drouin (Canada) |
| | | |
| 15:15 16:45 | | Symposium 57: What's new in congenital adrenal hyperplasia (CAH)?
Location: Hall E
Chairs: Chair(s): L. Ghizzoni (Italy) & N. Reisch (Germany)
|
| 15:15 | S57.1 S57.1 | Congenital adrenal hyperplasia: Counselling from birth to the next generation
N. Krone (UK) |
| | | |
| 15:45 | S57.2 S57.2 | CAH and adulthood
R. Ross (UK) |
| | | |
| 16:15 | S57.3 S57.3 | Optimal replacement therapy
N. Reisch (Germany) |
| | | |
| 15:15 16:00 | | Symposium 58: Best Clinical Practice
Location: Hall F
Chairs: P. Stewart (UK) & A. Peri (Italy)
|
| 15:15 | S58.1 S58.1 | Towards European guidelines for treatment of hyponatraemia
B. Allolio (Germany) |
| | | |
| 15:15 16:45 | | Symposium 59: Obesity and thyroid function
Location: Hall G
Chairs: Chair(s): C. Schalin-Jaentti (Finland) & E. Papini (Italy)
|
| 15:15 | S59.1 S59.1 | Obesity and thyroid function
T. Reinehr (Germany) |
| | | |
| 15:45 | S59.2 S59.2 | Thyroid regulation of energy balance: the role of the hypothalamus
A. Vidal-Puig (UK) |
| | | |
| 16:15 | S59.3 S59.3 | Type 2 deiodinase in muscle during health and disease
A. Boelen (The Netherlands) |
| | | |
| 15:15 16:45 | | Symposium 60: Performance enhancing hormones in sports
Location: Hall H
Chairs: Chair(s): M. Bidlingmaier (Germany) & J. Jorgensen (Denmark)
|
| 15:15 | S60.1 S60.1 | The spectrum of hormones in sports doping
F. Lanfranco (Italy) |
| | | |
| 15:45 | S60.2 S60.2 | Growth hormone and testosterone - do they work?
V. Birzniece (Australia) |
| | | |
| 16:15 | S60.3 S60.3 | Erythropoietin and its derivatives
M. Saugy (Switzerland) |
| | | |
| 17:00 17:15 | | ESE Young Investigator Awards & Poster Prizes
Generously supported by Novartis
Location: Main Hall
|
| 17:15 18:00 | | Plenary Lecture 5
Location: Main Hall
Chair: Chair(s): H. Kronenberg (USA)
|
| 17:15 | PL5 PL5 | Why your bones break - from childhood to old age
E. Seeman (Australia) |
| | | |
| 18:00 19:45 | | Poster Reception
Attended poster session, refreshments available
|
| 18:30 20:00 | | ELI LILLY Satellite Symposia - Therapeutic advances in Type 2 Diabets: achieving long-term glycaemic control, patient by patient
Location: Hall A
|
| 18:30 | | Pre-activity assessment
|
| | | |
| 18:35 | | iPod touch multimedia poster session
Poster 1 - Consensus and controversy in today's treatment landscape; Poster 2 - Emerging evidence and implications for treatment
S. Del Prato (Italy) |
| | | |
| 18:55 | | Live Case Presentations: Applying therapeutic advances to clinical practice
S. Del Prato & I. Raz (Italy & Israel) |
| | | |
| 19:35 | | Live Question & Answer Session
|
| | | |
| 19:45 | | iPod Touch Case-Based Video Presentation
F. Giorgino (Italy) |
| | | |
| 19:55 | | Post-activity Assessment
|
| | | |
| 20:00 | | Programme Adjournment
|
| | | |
| 18:30 20:00 | | Developing Endocrine Nursing across Europe and Internationally
Location: Polveriera
Chairs: Chair(s): M. Keil (USA) & P. Yeoh (UK)
|
| 18:30 | EN3.1 EN3.1 | Developing a nurse-led service in endocrinology
C. Follin (Sweden) |
| | | |
| 18:50 | EN3.2 EN3.2 | The role of nurse prescribing in the care of endocrine patients
S. Shalet (UK) |
| | | |
| 19:10 | EN3.3 EN3.3 | Developing an international endocrine nurse network - open discussion
Facilitators: M. Keil, USA & P.Yeoh, UK
|
| | | |
| 19:20 | | Announcement of Poster Prize, Posters display, networking and buffet meal
|
| | | |
| 20:30 23:00 | | ESE President's Dinner (Invitation Only)
|
| 9 May 2012 |
| 07:30 14:00 | | Registration
|
| 08:00 08:45 | | Plenary Lecture 6
Location: Main Hall
Chair: Chair(s): C. Deal (Canada)
|
| 08:00 | PL6 PL6 | Maternal nutrition, metabolism and fetal programming
C.S. Yajnik (India) |
| | | |
| 09:00 10:30 | | Symposium 61: New insights in thyroid cancer diagnosis
Location: Main Hall
Chairs: Chair(s): D. Fuehrer (Germany) & A. Lewinski (Poland)
|
| 09:00 | S61.1 S61.1 | BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status
M. Zatelli (Italy) |
| | | |
| 09:30 | S61.2 S61.2 | Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance
M. Milas (USA) |
| | | |
| 10:00 | S61.3 S61.3 | Does circulating thyroglobullin mRNA and protein levels predict early midterm thyroid cancer recurrence?
A. Pontecorvi (Italy) |
| | | |
| 09:00 10:30 | | Symposium 62: Early Development and Treatment of PCOS
Location: Hall A
Chairs: Chair(s): E. Diamanti-Kandarakis (Greece) & L. Ibanez (Spain)
|
| 09:00 | S62.2 S62.2 | Early development and pubertal prevention of polycystic ovary syndrome (PCOS)
F. de Zegher (Belgium) |
| | | |
| 09:30 | S62.1 S62.1 | Early hormonal abnormalities in children born to women with PCOS
T. Sir-Petermann (Chile) |
| | | |
| 10:00 | S62.3 S62.3 | Hyperandrogenism in obese girls - what is the significance?
C. McCartney (USA) |
| | | |
| 09:00 10:30 | | Symposium 63: Emerging ideas about phosphate metabolism
Location: Hall B
Chairs: Chair(s): O. Ljungren (Sweden) & T. Sugimoto (Japan)
|
| 09:00 | S63.1 S63.1 | Genetics of phosphate metabolism
M. Econs (USA) |
| | | |
| 09:30 | S63.2 S63.2 | FGF23: and tumour induced oestomalacia
S. Fukumoto (Japan) |
| | | |
| 10:00 | S63.3 S63.3 | FGF23 in chronic renal failure
J. Silver (Israel) |
| | | |
| 09:00 10:30 | | Symposium 64: Endoplasmic reticulum stress, obesity and metabolic homeostasis
Location: Hall C
Chairs: Chair(s): J. Romijn (The Netherlands) & TBC
|
| 09:00 | S64.1 S64.1 | Gut microbiota determine insulin sensitivity
M. Nieuwdorp (The Netherlands) |
| | | |
| 09:45 | S64.2 S64.2 | Endoplasmic reticulum stress plays a central role in development of leptin resistance
C. Yi (Munich) |
| | | |
| 10:00 | S64.3 S64.3 | P62, an autophagy hero or culprit?
H. Stenmark (Norway) |
| | | |
| 09:00 10:30 | | Symposium 65: Somatostatin receptors in pituitary
Location: Hall D
Chairs: Chair(s): J. Castano (Spain) & M. Gadelha (Brazil)
|
| 09:00 | S65.1 S65.1 | Imaging somatostatin activity in live pituitary
S. Schulz (Germany) |
| | | |
| 09:30 | S65.2 S65.2 | Is somatostatin receptor expression in adenomas related to pharmacological response?
S. Fougner (Norway) |
| | | |
| 10:00 | S65.3 S65.3 | Somatostatin receptors and filamin: a developing story
C. Bousquet (France) |
| | | |
| 09:00 10:30 | | Symposium 66: HPA axis, stress metabolism and adaptation
Location: Hall E
Chairs: Chair(s): D. Ray (UK) & M. Fleseriu (USA)
|
| 09:00 | S66.1 S66.1 | Neuroendocrine and (epi)genetic impact on HPA function
R. de Kloet (The Netherlands) |
| | | |
| 09:30 | S66.2 S66.2 | HPA programming through perinatal epigenetic modifications
M. Meaney (Canada) |
| | | |
| 10:00 | S66.3 S66.3 | Modulation of cortisol action
D. Ray (UK) |
| | | |
| 09:00 10:30 | | Symposium 67: Central regulation of energy homeostasis
Location: Hall F
Chairs: Chair(s): C. Strasburger (Germany) & A-M. Colao (Italy)
|
| 09:00 | S67.1 S67.1 | CNS control of energy and glucose metabolism
C. Koenner (Germany) |
| | | |
| 09:30 | S67.2 S67.2 | Gut hormones: history, physiology and therapeutic opportunities
K. Chandarana (UK) |
| | | |
| 10:00 | S67.3 S67.3 | Novel pharmacological approaches to treatment of diabetes and obesity
M. Tschoep (USA) |
| | | |
| 09:00 10:30 | | Symposium 68: European Network for the Study of Adrenal Tumours (ENSAT)
Location: Hall G
Chairs: Chair(s): F. Beuschlein (Germany) & M. Mannelli (Italy)
|
| 09:00 | S68.1 S68.1 | Genetics for Pheochromocytoma and paraganglioma in 2012
M. Robledo (Spain) |
| | | |
| 09:30 | S68.2 S68.2 | Diagnostic, prognostic and predictive factors in adrenocortical cancer
M. Papotti (Italy) |
| | | |
| 10:00 | S68.3 S68.3 | Update on hormonal markers as diagnostic and prognostic tools for adrenal lesions
W. Arlt (UK) |
| | | |
| 09:00 10:30 | | Symposium 69: Current progress in the management of thyroid cancer
Location: Hall H
Chairs: Chair(s): G. Brabant (Germany) & M Sahin (Turkey)
|
| 09:00 | S69.1 S69.1 | TSH suppression in differentiated thyroid cancer: How low should we go?
D. Cooper (USA) |
| | | |
| 09:30 | S69.2 S69.2 | rhTSH stimulated remnant ablation
M. Schlumberger (France) |
| | | |
| 10:00 | S69.3 S69.3 | Tyrosine kinase inhibitions in the management of progressing thyroid cancer
S. Sherman (USA) |
| | | |
| 09:00 10:30 | | Symposium 70: Young Active Researchers Symposium (YARE)
Location: Polveriera
Chairs: Chair(s): C. Quarta (Italy) & M. Bielohuby (Germany)
|
| 09:00 | S70.1 S70.1 | New mechanisms underlying the role of the mTORC1 pathway in the hypothalamic control of energy balance
D. Cota (France) |
| | | |
| 09:25 | S70.2 S70.2 | Control of brown adipose tissue thermogenisis by GLP-1 receptor signalling in the brain
D. Perez-Tilve (USA) |
| | | |
| 09:50 | S70.3 S70.3 | DNA methylation of the body weight-regulating proopiomelanocortin (POMC) gene: Functional and ontogenetic aspects
M. Mischke (Germany) |
| | | |
| 10:05 | S70.4 S70.4 | Mineralocorticoid receptor (MR) antagonism counters metabolic dysfunctions induced by high fat diet in mice
F. Cinti (Italy ) |
| | | |
| 10:20 | S70.5 S70.5 | A four-week fat overfeeding study in constitutional thin women: a human model of weight gain resistance
B. Galusca (France) |
| | | |
| 10:45 11:30 | | Plenary Lecture 7
Location: Main Hall
Chair: Chair(s): J. Tomlinson (UK)
|
| 10:45 | PL7 PL7 | Diabetes as a gut disease
M. Nauck (Germany) |
| | | |
| 11:30 11:45 | | Coffee, Posters & Exhibition
Exhibition Hall & Poster Hall
|
| 11:45 12:45 | | Debate 4: This house believes that we do more harm than good in the treatment of thyroid low risk carcinoma
For: I. Hay (USA); Against: H. Dralle (Germany)
Location: Main Hall
Chair: Chair(s): M. Alevizaki (Greece)
|
| 11:45 12:30 | | Meet the Expert 17 - Repeated
Location: Hall A
|
| 11:45 | MTE17 MTE17 | Multiple endocrine neoplasia type II
F. Raue (Germany) |
| | | |
| 11:45 12:30 | | Meet the Expert 18 - Repeated
Location: Hall B
|
| 11:45 | MTE18 MTE18 | Normocalcemic primary hyperparathyroidism
C. Marcocci (Italy) |
| | | |
| 11:45 12:30 | | Meet the Expert 19 - Repeated
Location: Hall C
|
| 11:45 | MTE19 MTE19 | Maturity onset diabetes of the young
A. Hattersley (UK) |
| | | |
| 11:45 12:30 | | Meet the Expert 20 - Repeated
Location: Hall D
|
| 11:45 | MTE20 MTE20 | The diagnosis and treatment of secondary osteoporosis in children
L. Ward (USA) |
| | | |
| 11:45 12:30 | | Meet the Expert 21 - Repeated
Location: Hall E
|
| 11:45 | MTE21 MTE21 | Autoimmune hyperthyroidism - initiation and duration of thionamide therapy
P. Laurberg (Denmark) |
| | | |
| 11:45 12:30 | | Meet the Expert 22 - Repeated
Location: Hall F
|
| 11:45 | MTE22 MTE22 | Clinical management in transgender sex hormone treatment
G. T'Sjoen (Belgium) |
| | | |
| 11:45 12:30 | | Meet the Expert 23 - Repeated
Location: Hall G
|
| 11:45 | MTE23 MTE23 | Subclinical hypothyroidism
B. Biondi (Italy) |
| | | |
| 11:45 12:30 | | Meet the Expert 24 - Repeated
Location: Hall H
|
| 11:45 | MTE24 MTE24 | Approach to the management of the infertile couple
A. Lenzi (Italy) |
| | | |
| 12:45 13:30 | | Meet the Expert 25 - Repeated
Location: Hall A
|
| 12:45 | MTE25 MTE25 | Pituitary incidentalomas
S. Tsagarakis (Greece) |
| | | |
| 12:45 13:30 | | Meet the Expert 26 - Repeated
Location: Hall B
|
| 12:45 | MTE26 MTE26 | PCOS
E. Diamanti-Kandarakis (Greece) |
| | | |
| 12:45 13:30 | | Meet the Expert 27 - Repeated
Location: Hall C
|
| 12:45 | MTE27 MTE27 | Differential diagnosis of Cushing's syndrome
J. Salvadore (Spain) |
| | | |
| 12:45 13:30 | | Meet the Expert 28 - Repeated
Location: Hall D
|
| 12:45 | MTE28 MTE28 | Hypoglycaemia and diabetes management
W. Sheu (Taiwan) |
| | | |
| 12:45 13:30 | | Meet the Expert 29 - Repeated
Location: Hall E
|
| 12:45 | MTE29 MTE29 | Management of bone loss induced by cancer treatment in early breast and prostate cancer
J. Body (Belgium) |
| | | |
| 12:45 13:30 | | Meet the Expert 30 - Repeated
Location: Hall F
|
| 12:45 | MTE30 MTE30 | Treatment of vitamin D deficiency
N. Tandon (India) |
| | | |
| 12:45 13:30 | | Meet the Expert 31 - Repeated
Location: Hall G
|
| 12:45 | MTE31 MTE31 | Cryptorchidism
J. Toppari (Finland) |
| | | |
| 12:45 13:30 | | Meet the Expert 32 - Repeated
Location: Hall H
|
| 12:45 | MTE32 MTE32 | Management of GEP-NET tumours
K. Oberg (Sweden) |
| | | |
| 13:40 14:25 | | Plenary Lecture 8
Location: Main Hall
Chair: Chair(s): M. Mclean (Australia)
|
| 13:40 | PL8 PL8 | Novel molecular link between the circadian clock and hypertension
H. Okamura (Japan) |
| | | |
| 14:25 14:30 | | Farewell & Invitation to ECE 2013 Copenhagen
J. Castaňo (Spain) & J. Christiansen (Denmark)
Location: Main Hall
|
| 14:30 | | Post Congress Courses / Post Congress Industry Sponsored Satellite Symposia
|